Company / Cash per Share
Ernexa Therapeutics Inc. Cash per Share History
FY2014-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.48
FY2023
5-year range
$1.12 / $1.48
FY2019-FY2023
Trend
-
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has increased for 3 consecutive years, from $0.06 in FY2017 to $1.48 in FY2023.
Based on SEC 10-K filings.
1.48 in FY2023 with a 5-year CAGR of +8.0%.
Improved from $1.01 to $1.48 over the past 5 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +8.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- Peak cash per share was recorded in FY2016.
- Lowest cash per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $1.48 | - |
| FY2020 | - | - |
| FY2019 | $1.12 | +11.0% |
| FY2018 | $1.01 | +1535.4% |
| FY2017 | $0.06 | -96.5% |
| FY2016 | $1.74 | +2140.9% |
| FY2015 | $0.08 | +12.1% |
| FY2014 | $0.07 | +81.3% |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026